Dr. Enrique A. Escalon
Claim this profileNicklaus Children's Hospital
Expert in Tumors
Expert in Brain Tumor
37 reported clinical trials
81 drugs studied
About Enrique A. Escalon
Education:
- Earned a Medical Degree from the University of El Salvador Medical School.
Experience:
- Completed Residency at Nicklaus Children's Hospital, serving as Chief Resident in 1974.
- Undertook a Fellowship in Pediatric Hematology-Oncology at Nicklaus Children's Hospital.
- Board Certified in Pediatrics and Pediatric Hematology-Oncology.
- Served as the Director of the Division of Hematology-Oncology at Nicklaus Children's Hospital since the 1980s.
- Founded the Cancer and Blood Disorders Institute at Nicklaus Children's Hospital, significantly contributing to its growth.
Area of expertise
1Tumors
Global LeaderStage I
Stage II
Stage IV
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Nicklaus Children's Hospital
Clinical Trials Enrique A. Escalon is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Enrique A. Escalon
Clinical Trial Related7 years of experience running clinical trials · Led 37 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Enrique A. Escalon has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Cisplatin
- Thioguanine
- Vincristine Sulfate
Breakdown of trials Enrique A. Escalon has run
Tumors
Brain Tumor
Cancer
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Enrique A. Escalon specialize in?
Enrique A. Escalon focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Enrique A. Escalon currently recruiting for clinical trials?
Yes, Enrique A. Escalon is currently recruiting for 8 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Enrique A. Escalon has studied deeply?
Yes, Enrique A. Escalon has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Enrique A. Escalon?
Apply for one of the trials that Enrique A. Escalon is conducting.
What is the office address of Enrique A. Escalon?
The office of Enrique A. Escalon is located at: Nicklaus Children's Hospital, Miami, Florida 33155 United States. This is the address for their practice at the Nicklaus Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.